Form 8-K - Current report:
SEC Accession No. 0001683168-23-004326
Filing Date
2023-06-21
Accepted
2023-06-21 16:46:00
Documents
14
Period of Report
2023-06-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT avid_8k.htm   iXBRL 8-K 32427
2 PRESS RELEASE avid_ex9901.htm EX-99.1 100336
6 GRAPHIC image_001.jpg GRAPHIC 4019
  Complete submission text file 0001683168-23-004326.txt   325101

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cdmo-20230621.xsd EX-101.SCH 2956
4 XBRL LABEL FILE cdmo-20230621_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cdmo-20230621_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT avid_8k_htm.xml XML 3484
Mailing Address 14191 MYFORD ROAD TUSTIN CA 92780
Business Address 14191 MYFORD ROAD TUSTIN CA 92780 714.508.6100
Avid Bioservices, Inc. (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-32839 | Film No.: 231030504
SIC: 2834 Pharmaceutical Preparations